Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYPLOS One

Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria

6 more authors
15 affiliations
  1. 1Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Enugu Campus, Enugu, Nigeria.
  2. 2Vaccine Research Center, University of Nigeria, Enugu, Nigeria.
  3. 3IVAN Research Institute, University of Nigeria, Enugu, Nigeria.
  4. 4Interdisciplinary Health Sciences, University of Texas at El Paso, El Paso, Texas, United States of America.
  5. 5Department of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
  6. 6Excellence Community Education Welfare Scheme (ECEWS), Abuja, Nigeria.
  7. 7Department of Anatomy and Molecular Pathology, Lagos University Teaching Hospital, Lagos, Nigeria.
  8. 8Department of Biological Sciences, Faculty of Natural and Applied Sciences, Lead City University, Ibadan, Oyo State, Nigeria.
  9. 9Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
  10. 10Department of Virology, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
  11. 11Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Federal University of Health Sciences, Ila-Orangun, Osun State, Nigeria.
  12. 12Department of Epidemiology, University of Chicago, Chicago, Illinois, United States of America.
  13. 13Ministry of Defense Health Implementation Program, Abuja, Nigeria.
  14. 14Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
  15. 15Infectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.

Abstract

Women living with HIV (WLHIV) are at significantly higher risk of persistent high-risk human papillomavirus (hrHPV), and consequently, cervical cancer. However, large scale data on the epidemiology of hrHPV genotypes among WLHIV are limited in Nigeria. The study aimed to determine the prevalence and distribution of hrHPV among WLHIV in Nigeria. We conducted a cross-sectional study among 1327 WLHIV aged 25−60 years receiving HIV care from six selected Nigeria Implementation Science Alliance–Model Innovation and Research Centers (NISA-MIRCs) across Nigeria. Cervical swabs were obtained, and HPV DNA genotype was determined using the Hybribio Genoarray assay that detects 37 HPV genotypes including 14 high-risk HPVs. Sociodemographic and clinical data were collected using interviewer-administered structured questionnaire. Factors independently associated with hrHPV infection were identified using multivariable logistic regression. Statistical analysis was performed using R statistical software (version 4.4.1) with significance set at p < 0.05. Among the 1105 participants with analyzable samples, the overall HPV and hrHPV prevalence were 30.9% and 22.1%, respectively, with regional differences. Non-HPV 16 and 18 accounted for nearly two-thirds (67.6%) of hrHPV infections. The top five most often detected hrHPVs were HPV-58 (14.2%), HPV-16 (12.7%), HPV-52 (12.4%), HPV-31 (10.6%), and HPV-18 (10.3%). In a multivariate analysis, ART usage for one year or less was associated with hrHPV infection (aOR = 8.2, 95% CI 4.3–16.0). This multi-site study showed a significant and genotype-diverse burden of hrHPV among HIV-positive women in Nigeria, with most infections caused by non-HPV16/18 variants. These findings emphasize the need for increased integration of cervical cancer screening within HIV care and support the call for HPV vaccines with broader genotype coverage beyond HPV 16 and 18 to address the prevailing genotype distribution in this population.

Related

  1. Prevalence of high-risk human papillomavirus genotypes and associated factors among HIV-infected women in a reproductive age group attending antiretroviral therapy in Nekemte town, Oromia, Ethiopia
    Rundase Gebeyehu, Seifu Gizaw, Desta Amensisa +4
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyMicrobiologyPLOS
  2. Prevalence and distribution of parasitic infections among HIV-positive adults attending antiretroviral therapy clinics in South-West Nigeria.
    Tajudeen Olusegun Uthman, Fatima Salihu, Oladunni Nimota Adekunle +1
    Parasitology researchPeer-reviewedCC BY-NC-NDFull textMicrobiologyEurope PMCPMC
  3. Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis
    Kendall A Lawley, Karthikeya Kusuma, Stephanie A Farquhar +2
    PLOS OnePeer-reviewedCC BYFull textImmunologyStatisticsPLOSEurope PMCPMC
  4. Prevalence of Gastrointestinal Parasites in Goats and Sheep in Mbula Kuli, Adamawa State, Nigeria
    Ayman Bello Sumda
    EcoEvoRxivPreprintPublisher termsFull textEcologyEcoEvoRxiv
  5. Tracking the Global Prevalence and Distribution of the AmpC-β-Lactamase-Carrying pESM Megaplasmid in Salmonella Minnesota
    Anamaria M. P. Dos Santos, Ana Beatriz Portes, Hannay Crystynah Almeida De Souza +4
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
BibTeX
@article{ifeorah2026prevalence,
  title = {{Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria}},
  author = {Ijeoma M Ifeorah and Jonadab Chinwendu and Stanley C Eneh and Babayemi O Olakunde and Uduak Akpan and Nicholas A Awolola and Uwem E George and Temitope O C Faleye and Popoola Bolutife and Chukwuma E Omoruyi and Chinonso C Iyi and Carey Tishiya and Emo A Ivo and Adekunbiola A F Banjo and Chibuike O Chigbu and Lifang Hou and Echezona E Ezeanolue and Olubusuyi M Adewumi},
  journal = {PLOS One},
  year = {2026},
  month = nov,
  doi = {10.1371/journal.pone.0360438},
  url = {https://doi.org/10.1371/journal.pone.0360438},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria
AU  - Ijeoma M Ifeorah
AU  - Jonadab Chinwendu
AU  - Stanley C Eneh
AU  - Babayemi O Olakunde
AU  - Uduak Akpan
AU  - Nicholas A Awolola
AU  - Uwem E George
AU  - Temitope O C Faleye
AU  - Popoola Bolutife
AU  - Chukwuma E Omoruyi
AU  - Chinonso C Iyi
AU  - Carey Tishiya
AU  - Emo A Ivo
AU  - Adekunbiola A F Banjo
AU  - Chibuike O Chigbu
AU  - Lifang Hou
AU  - Echezona E Ezeanolue
AU  - Olubusuyi M Adewumi
PY  - 2026
DA  - 2026/11/10
JO  - PLOS One
DO  - 10.1371/journal.pone.0360438
UR  - https://doi.org/10.1371/journal.pone.0360438
AB  - Women living with HIV (WLHIV) are at significantly higher risk of persistent high-risk human papillomavirus (hrHPV), and consequently, cervical cancer. However, large scale data on the epidemiology of hrHPV genotypes among WLHIV are limited in Nigeria. The study aimed to determine the prevalence and distribution of hrHPV among WLHIV in Nigeria. We conducted a cross-sectional study among 1327 WLHIV aged 25−60 years receiving HIV care from six selected Nigeria Implementation Science Alliance–Model Innovation and Research Centers (NISA-MIRCs) across Nigeria. Cervical swabs were obtained, and HPV DNA genotype was determined using the Hybribio Genoarray assay that detects 37 HPV genotypes including 14 high-risk HPVs. Sociodemographic and clinical data were collected using interviewer-administered structured questionnaire. Factors independently associated with hrHPV infection were identified using multivariable logistic regression. Statistical analysis was performed using R statistical software (version 4.4.1) with significance set at p < 0.05. Among the 1105 participants with analyzable samples, the overall HPV and hrHPV prevalence were 30.9% and 22.1%, respectively, with regional differences. Non-HPV 16 and 18 accounted for nearly two-thirds (67.6%) of hrHPV infections. The top five most often detected hrHPVs were HPV-58 (14.2%), HPV-16 (12.7%), HPV-52 (12.4%), HPV-31 (10.6%), and HPV-18 (10.3%). In a multivariate analysis, ART usage for one year or less was associated with hrHPV infection (aOR = 8.2, 95% CI 4.3–16.0). This multi-site study showed a significant and genotype-diverse burden of hrHPV among HIV-positive women in Nigeria, with most infections caused by non-HPV16/18 variants. These findings emphasize the need for increased integration of cervical cancer screening within HIV care and support the call for HPV vaccines with broader genotype coverage beyond HPV 16 and 18 to address the prevailing genotype distribution in this population.
SN  - 1932-6203
ER  -